FRI0270 Does Immunogenicity Influence on Drug Survival of Anti-TNF?

Background Biological therapies have improved the treatment of Rheumatoid Arthritis (RA) in the last decade. The development of anti-TNF antibodies has been found crucial to drug efficacy and survival. All monoclonal antibodies are immunogenic, whereas the fusion proteins, like Etanercept, have prov...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2014-06, Vol.73 (Suppl 2), p.481
Hauptverfasser:	García-Carazo, S., Plasencia, C., Pascual-Salcedo, D., Lopez-Casla, M., Moral, R., Nuño, L., Bonilla Hernán, G., Villalba, A., Peiteado, D., Díaz, M., Martin-Mola, E., Balsa, A.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!